Owkin and Evotec partner to accelerate therapeutics in oncology and I&I
The companies will aim to select targets, discover and develop new therapeutics
Read More
Tag: r&d
UKRI awards £41m to enhance UK research and innovation
The scheme will help ten projects establish research and innovation clusters
Read More
AstraZeneca reveals new research to improve drug discovery
The study used data from 50,000 people in the UK Biobank
Read More
PrecisionLife and Ono Pharmaceutical enter into new R&D link up
R&D partnership will identify and develop novel therapeutic targets for future therapies
Read More
State-of-the-art R&D facilities to be developed in Oxford city centre
Site will include creating space for student accommodation, offices, retail outlets and restaurants
Read More
Bayer establishes new cell and gene therapy platform
Platform will enable Bayer to pursue external collaborations and bolster internal capabilities
Read More
Mixed reaction to chancellor’s spending review
Chancellor Rishi Sunak hands out extra £3 billion to NHS and £14.6 billion in funding for R&D
Read More
Pharma industry invests £377m in UK R&D collabs
ABPI chief said that the investment from companies is “excellent news at a time of economic uncertainty and signals the strength of the sector in the UK.”
Read More
Oxford Biomedica, Santen enter retinal disease R&D alliance
Inherited retinal diseases are ideal candidates for gene therapy because many of the responsible genetic mutations have already been identified.
Read More
Record number of cancer drugs launched in 2018, says report
The IQVIA report also explores health system barriers hindering the realisation of the benefits of those therapies and drug candidates.
Read More
R&D SMEs at risk due to tax credit scheme change
The aim is to prevent fraud, but analysis by the BIA shows the measure will have unintended consequences for life science companies.
Read More
UK should be “proud” of service and supply sector
Service and supply companies account for 80% of small and medium enterprises (SMEs) in UK medicines discovery, and 90% of employment.
Read More
- Francis Crick, UCL and AZ identify why treatment fails for NSCLC patients
- Royal Marsden launches first UK genome testing facility to improve testing for cancer
- Sysmex receives Longitude Prize on AMR for antimicrobial testing system
- LifeArc funds new projects to address and prevent global threat of dengue fever
- New study reveals how brain cell communication is linked to Alzheimer’s disease
